SCN2A and tuberous sclerosis: SE in defined electroclinical syndrome 50% (Ohtahara syndrome, IS due to SCN2A pathogenic variant, TSC); progressive 37.5% (Alpers syndrome); Unknown 12.5% (FIRES)